Day One Biopharmaceuticals Inc (DAWN) — Financial Flexibility Index
Day One Biopharmaceuticals Inc (DAWN) has a Financial Flexibility Index of -0.03x as of September 2025. Free cash flow of $-1.99 Million (operating CF $-5.80 Million minus capex $3.82 Million) represents 0% of total liabilities ($62.91 Million). Check DAWN capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Day One Biopharmaceuticals Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Day One Biopharmaceuticals Inc across 6 annual periods. For the full cash flow conversion analysis, see how efficiently does Day One Biopharmaceuticals Inc generate cash.
Annual Financial Flexibility Index for Day One Biopharmaceuticals Inc (2019–2024)
Year-by-year free cash flow to debt coverage for Day One Biopharmaceuticals Inc. Explore DAWN cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.95x | $-75.94 Million | $-78.11 Million | $80.04 Million | ▲ +80.5% |
| 2023 | -4.87x | $-143.63 Million | $-146.85 Million | $29.51 Million | ▲ +24.6% |
| 2022 | -6.45x | $-109.85 Million | $-109.87 Million | $17.02 Million | ▼ -38.1% |
| 2021 | -4.67x | $-40.54 Million | $-48.54 Million | $8.67 Million | ▲ +23.2% |
| 2020 | -6.09x | $-13.40 Million | $-13.49 Million | $2.20 Million | ▼ -4378.0% |
| 2019 | -0.14x | $-4.42 Million | $-4.51 Million | $32.52 Million | — |